Combination of Aspirin and an Anti-Clotting Drug Reduces Risk of Dialysis Access Failure – 4
Narrator: This is NIH Health Matters. There are different ways for physicians to set up what is called an "access" for hemodialisis, a kidney replacement therapy.
Dr. Meyers: Catheters are considered temporary because they can become infected or readily pulled out.
Narrator: That’s Dr. Catherine Meyers at the National Institute of Diabetes and Digestive and Kidney Diseases. She explains that AV grafts, another “access” for hemodialysis can also fail.
Dr. Meyers: It’s a tremendous burden on patients when an access fails, because they are therefore committed to further invasive procedures and additional surgeries.
Narrator: A new study has shown a promising drug combination – dipyridamole and aspirin – that extends the life of an AV graft. For more information, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.